HLA Typing Market is Expected to Reach CAGR of 6% by the End of 2030
HLA Typing Market Overview:
The global HLA
typing market is expected to expand at a compound annual growth rate (CAGR)
of approximately 6% during the forecast period. Market growth is driven by the
rising demand for organ and tissue transplantation, continuous advancements in
molecular diagnostics—particularly next-generation sequencing (NGS) and
PCR-based technologies—expanding applications of HLA typing in infectious
disease research, increasing numbers of stem cell and bone marrow transplants,
and the growing prevalence of autoimmune disorders and cancers. In addition,
greater public awareness and improved organ donation rates worldwide are
further supporting market expansion.
Download Sample PDF Copy: https://meditechinsights.com/hla-typing-market/request-sample/
Report Overview
Human leukocyte antigen (HLA) testing, also referred to
as HLA or tissue typing, is a genetic diagnostic procedure used to identify
antigens present on the surface of cells and tissues. Its primary role is to
assess compatibility between transplant donors and recipients, which is
critical for minimizing immune-mediated rejection. HLA testing also enables the
detection of pre-existing antibodies in transplant recipients that may target
donor tissues, directly influencing transplant outcomes. The extent of donor-recipient
matching required varies by transplant type, thereby determining the specific
HLA genes and testing methodologies employed.
Advancements in molecular diagnostics
accelerate HLA typing adoption
Since the introduction of polymerase chain reaction
(PCR), DNA-based methods have become the standard in HLA typing laboratories
due to their superior accuracy, sensitivity, reproducibility, and resolution.
Commonly used techniques include PCR with sequence-specific primers (SSP),
sequence-specific oligonucleotides (SSO), real-time PCR, sequencing-based
typing (SBT), and next-generation sequencing (NGS).
Among these, NGS—also known as high-throughput
sequencing—is increasingly favored as the preferred HLA typing technology. Its
ability to deliver high-resolution results with greater speed and throughput,
while resolving allele ambiguities at costs comparable to SBT, has
significantly enhanced its adoption. NGS workflows involve DNA library
preparation, targeted gene amplification using emulsion or solid-phase PCR,
sequencing, and alignment against reference databases such as the IMGT/HLA
database. Ongoing improvements in sequencing platforms, coupled with artificial
intelligence integration, have further enhanced automation, portability,
accuracy, and operational efficiency. As diagnostic technologies advance, the
combined use of qPCR and NGS is becoming increasingly critical to address the
growing demand for precision and personalized medicine, particularly in
oncology, where rapid and accurate genetic insights can directly inform
treatment decisions.
Download Sample PDF Copy: https://meditechinsights.com/hla-typing-market/request-sample/
Rising organ transplantation demand
fuels market growth
According to data from the World Health Organization
(WHO), the Global Observatory on Donation and Transplantation (GODT), and the
Organización Nacional de Trasplantes (ONT), global organ donation and
transplantation activity continues to rise. The 2023 International Report on
Organ Donation and Transplantation reported a 9.5% year-on-year increase in
solid organ transplants, reaching 172,397 procedures worldwide. This growth is
largely attributed to the increasing burden of end-stage organ failure, including
kidney, liver, heart, and lung diseases. Chronic conditions such as diabetes,
hypertension, and cardiovascular disorders remain major contributors to kidney
failure, while hepatitis, cirrhosis, and alcohol-related liver disease continue
to drive demand for liver transplantation.
As transplant volumes increase, accurate
donor-recipient matching has become more critical than ever. HLA typing plays a
central role in improving transplant outcomes by reducing rejection risk and
enhancing long-term graft survival. High-precision HLA typing is particularly
vital in kidney, bone marrow, liver, and heart transplants, where compatibility
significantly affects success rates. Consequently, the growing need for organ
and tissue transplantation is directly driving demand for advanced HLA typing
solutions.
Competitive Landscape Analysis
The global HLA typing market comprises a mix of
established and emerging players, including Thermo Fisher Scientific Inc.,
Bio-Rad Laboratories Inc., QIAGEN N.V., Omixon Inc., GenDx, Illumina Inc., TBG
Diagnostics Limited, Becton, Dickinson and Company, Takara Bio Inc., F.
Hoffmann-La Roche Ltd., Pacific Biosciences, Immucor, Inc., and CareDx, Inc.,
among others. Key competitive strategies adopted by these companies include new
product launches, strategic partnerships and collaborations, and continued
investment in research and development to strengthen technological capabilities
and market presence.
Browse Research Report: https://meditechinsights.com/hla-typing-market/
Market Segmentation
This report by Medi-Tech Insights provides the size
of the global HLA typing market at the regional and country levels from 2023
to 2030. The report further segments the market based on technology, product
and service, application, and end user.
·
Market Size & Forecast
(2023-2030), By Technology, USD Million
o Molecular Assay
§ PCR
§ Next Generation Sequencing
o Non-Molecular Assay
·
Market Size & Forecast
(2023-2030), By Product & Service, USD Million
o Reagents & Consumables
o Instruments
o Software & Services
·
Market Size & Forecast
(2023-2030), By Application, USD Million
o Diagnostic Applications
§ Donor-Recipient Cross-Matching
§ Infectious Disease Testing
§ Cancer Diagnosis & Prevention
§ Transfusion Therapy
§ Other Diagnostic Applications
o Research Applications
·
Market Size & Forecast
(2023-2030), By End User, USD Million
o Commercial Service Providers
o Hospitals & Surgical Centers
o Research Laboratories & Academic Institutes
·
Market Size & Forecast
(2023-2030), By Region, USD Million
o North America
§ US
§ Canada
o Europe
§ UK
§ Germany
§ France
§ Italy
§ Spain
§ Rest of Europe
o Asia Pacific
§ China
§ India
§ Japan
§ Rest of Asia Pacific
o Latin America
o Middle East & Africa
Related Report:
Dental 3D Printing Market - https://www.pharmiweb.com/press-release/2026-01-30/dental-3d-printing-market-2030-size-share-growth-analysis-and-research-report-to-forecast
Antibody Testing Market - https://www.pharmiweb.com/press-release/2026-01-30/antibody-testing-market-growth-opportunities-sales-trends-service-applications-and-forecast-2030
Vaccine CDMO Market - https://www.pharmiweb.com/press-release/2026-01-30/vaccine-cdmo-market-strategy-revenue-opportunity-business-segment-overview-and-key-trends-2026-2030
Pulse Oximeter Market - https://www.pharmiweb.com/press-release/2026-01-30/pulse-oximeter-market-2026-growth-opportunities-sales-trends-service-applications-and-forecast-2030
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment